INSTITUTIONAL DISTINCTIVENESS

ADVERSE DRUG MONITOTRING CENTRE

An Adverse Drug Reaction (ADR) is an unintended and harmful reaction that occurs after the administration of prescription medications, over-the-counter drugs, and dietary supplements. ADRs can range from mild side effects, such as skin rashes or gastrointestinal problems, to severe reactions, such as anaphylaxis or organ damage. Some ADRs may also be life-threatening.

Among all the dental colleges, YMTDCH has pioneered in having adverse drug reaction monitoring department dedicatedly working for the same under Pharmacovigilance Commission of India (PvPi).

An adverse drug reaction (ADR) department is a specialized unit within our institute responsible for monitoring and managing adverse drug reactions. It focuses more on oral adverse drug reactions and their reporting.

During the month SEPT 2021,YMTDCH formed the committee, comprising of members from all the departments which will monitor the adverse drug related events in the YMTDCH. The ADMC unit was inaugurated by Dean and Professor Dr. Meghna Vandekar and the head of departments.

Scope / Objectives of ADMC in YMTDCH:

• To monitor the ADR
• To optimize safe and effective use of medicines act in YMTDCH.
• To create awareness amongst health care professionals about the importance of ADR reporting.
• To monitor benefit-risk profile of medicines.
• Generate independent, evidence-based recommendations on the safety of medicines.
• Support the CDSCO for formulating safety related regulatory decisions for medicines.
• Communicate findings with all key stakeholders.
• To comply with adherence of global drug safety monitoring standards of WHO.

The main responsibilities of an ADR department in our institute include:

• Monitoring and tracking adverse drug reactions: The department collects and analyses data on adverse drug reactions reported by institute doctors from all the departments and patients.
• Investigating the causes of adverse drug reactions: The ADMC carries out investigations to determine the underlying causes of adverse drug reactions, including the type of medication, dosage, and patient characteristics.
• Developing preventive measures: The ADMC develops and implement measures to reduce the risk of adverse drug reactions, such as modifying medication regimens or updating drug information.
• Providing education and training: The ADMC provides education and training to under graduation as well as post-graduation students of the YMTDCH and patients on the recognition and management of adverse drug reactions.
• Reporting adverse drug reactions: The ADMC is responsible for reporting adverse drug reactions to regulatory agencies and other relevant organizations.

After reporting the data in ADR form, it is documented and mailed to PvPi for signalling and document is reported.

The ultimate goal of an YMTDCH ADMC department is to improve patient safety by minimizing the risk of adverse drug reactions and providing effective management and treatment when they occur.